SCHEMBL24009148

SCHEMBL24009148

COc1cccc2c(C)c(C#N)cnc12

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 1/20 0.55
▸ SLC6A3 Q01959 1/20 0.53
▸ ATP4A P20648 3/20 0.46
▸ ATP4B P51164 3/20 0.46
▸ SRC P12931 1/20 0.45
▸ IMPDH2 P12268 1/20 0.45
▸ IMPDH1 P20839 1/20 0.45
▸ EGFR P00533 1/20 0.43
▸ ERBB2 P04626 1/20 0.43
▸ HTR1A P08908 1/20 0.42
▸ ADRA1D P25100 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ ADRA1B P35368 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24393199 0.87 SLC6A3 (0.41) HPGDSSLC6A3ATP4AATP4BSRC
SCHEMBL6381401 0.84 HPGDS (0.54) HPGDSSLC6A3SRCIMPDH2IMPDH1
SCHEMBL16132474 0.82 CCR1 (0.57) HPGDSATP4AATP4BHTR1AADRA1D
SCHEMBL24392645 0.81 HPGDS (0.51) HPGDSSLC6A3SRCIMPDH2IMPDH1
SCHEMBL24391743 0.81 HPGDS (0.51) HPGDSSLC6A3ATP4AATP4BSRC
SCHEMBL24715854 0.78 HTR1A (0.55) HPGDSSLC6A3IMPDH2IMPDH1HTR1A
SCHEMBL6381081 0.75 EGFR (0.56) SRCEGFRERBB2
SCHEMBL5256736 0.74 IMPDH2 (0.48) HPGDSSLC6A3SRCIMPDH2IMPDH1
SCHEMBL16132482 0.74 CCR1 (0.55) —
SCHEMBL6382190 0.73 EGFR (0.54) HPGDSSLC6A3SRCEGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022091048-A1 ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (ENPP1) INHIBITORS AND USES THEREOF INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2022-05-05 — — WO disclosed
WO-2021225969-A1 IMINO SULFANONE INHIBITORS OF ENPP1 VOLASTRA THERAPEUTICS, INC. (US) 2021-11-11 — — WO disclosed
Send feedback